Industry Sectors

With our comprehensive knowledge and deep experience navigating complex healthcare regulations together with our practical understanding of the unique challenges and commercial issues faced by players in this industry, we have been actively assisting our clients in the healthcare and related industry (e.g. healthcare service providers, pharmacies, pharmaceutical companies, medical devices distributors and etc.) on a broad range of issues and helping them achieving their commercial objectives through regulatory conditions with practical solutions and best-in-class service.

Over the past decade or so, our team has represented clients of all sizes ranging from start-ups to leading healthcare service providers and global pharmaceutical companies. Our services include various types of transactions, including merger and acquisitions, joint ventures, internal restructuring, foreign direct investment, fund raising via debts and equity (both within and outside of Thailand), business cooperation and general commercial transactions as well as advice on regulatory compliance and related issues.

Notable transactions include:

• Advised a leading global science-based nutrition and health group on the spin-off of one of its business units, and relevant regulatory approvals and filings


• Advised on the IPO and listing of Bangkok Lab and Cosmetic


• Advised Apex Medical Center, one of Thailand’s leading operators in the cosmetic surgery industry, on its joint venture with 365mc, a leading and award-winning Korean hospital specialising in advanced obesity treatment and liposuction services, to operate liposuction services using newly advanced technology


• Advised Navis Capital Partners on the acquisition of N.P. Medical, a licence holder of S-Spine Hospital and RMC Clinic


• Advised Linden Capital Partners on (i) its indirect acquisition of the entire equity interest in Suretex, a Thai subsidiary of LifeStyles Healthcare, a global sexual health and wellness platform, as part of its global acquisition of LifeStyles Healthcare, and (ii) its USD 200 million syndicated financing for the preceding acquisition


• Advised the founders of Unison Group, a leading pharmaceutical and healthcare manufacturer and distributor, on the disposal of its entire equity interest in the group's companies to B.Grimm Healthcare


• Advised Principal Healthcare, a subsidiary of PRINC, on its acquisition of a majority interest in Pewdee Clinic, a chain of renowned aesthetic clinics in Thailand


• Advised Sanofi Group with respect to the internal restructuring and business transfer of its subsidiaries in Thailand to spin-off its consumer healthcare business as a standalone business unit under Opella Healthcare


• Advised on the joint venture between PharmCare Group, an operator of a health tech platform called “PharmCare” and Humanica


• Advised Principal Capital, one of the leading players in Thailand’s healthcare industry, in connection with an investment by RATCH Group under the General Mandate Scheme


• Advised SGS Capital on the acquisition of Gifted IVF Udon Thani Clinic, a company engaged in the operation of an In-Vitro Fertilisation (IVF) clinic in Thailand


• Advised PharmCare Group on its commercial contracts with certain qualified pharmacies and other healthcare service providers as well as its partnered insurance companies in relation to its web-based platform called “PharmCare”


• Advised on the joint venture between Principal Capital and its local partners in a company operating PRINC – Srisaket Hospital


• Advised DKSH on its acquisition of the entire distribution operations of scientific and laboratory devices from a group of sellers who are leaders in the distribution of scientific and laboratory devices in Thailand


• Advised on the disposal of the entire interest in Lavida Advanced Fertility and Genetic Centers, which provides premium assisted reproductive technology (ART) services, including in-vitro fertilization (IVF) and egg freezing


• Advised on the disposal by Asvatanakul Family in Takeda Thailand, a subsidiary of Japan’s largest pharmaceutical company, Takeda Pharmaceutical, by way of an entire business transfer and sale of shares


• Advised Humanwell Healthcare on the acquisition of Ansell, Thailand’s leading sexual wellness business,and related financing


• Advised Principal Capital on the acquisition of a number of hospitals throughout Thailand, including Paknampho Hospital, Sahavej Hospital, Pitsanuvej Hospital, Piyamin Hospital (currently, Princ Hospital Suvarnabhumi), and Virajsilp Hospital


• Advised Paolo Medic, a subsidiary of Bangkok Dusit Medical Services (BDMS), on the acquisition of the entire business of Mayo Polyclinic


• Advised Bangkok Dusit Medical Services (BDMS) Group on the acquisition of the entire business of a number of hospitals nationwide, including Muangraj Hospital in Ratchaburi, Phuket International Hospital in Phuket, Sanamchan Hospital, Ratanavej Hospital and Ratanavej Children Hospital in Phitsanulok


• Advised on the disposition by the founders in Accord Corporation to Henry Schein, a Nasdaq-listed company and a worldwide distributor of medical and dental supplies including vaccines, pharmaceuticals, financial services and equipment


• Advised Bangkok Dusit Medical Services (BDMS) Group on the acquisition of Save Drug Center, a renowned pharmacy chain with countrywide outlets


• Advised on the issue and offering, and the subsequent invitation to tender and repurchase, by Bangkok Dusit Medical Services (BDMS) of USD 124 million convertible bonds due 2011


• Placement of new shares in Bumrungrad Hospital following the conversion of convertible bonds by Bangkok Bank